PMA P880081S042

Device
TECNIS CL Foldable Silicone Intraocular Lens
Applicant
Johnson & Johnson Surgical Vision, Inc.
PMA number
P880081
Supplement
S042
Product code
HQL
Decision date
2019-04-05
Classification
Intraocular Lens
Generic name
intraocular lens
Approval order statement
Approval to revise the TECNIS® CL, Model Z9002, Directions for Use (DFU) to inform the user of the interaction of silicone material with inherent risk factors (such as asteroid hyalosis) as follows:1) Addition of diabetic retinopathy as an example in Warning #10 to state: The use of silicone lenses in patients with current vitreoretinal disease or those who are at high risk for future vitreoretinal disease (i.e. diabetic retinopathy, etc.) that may require silicone oil as part of therapy should be reconsidered; and2) Addition of the following Warning #11: The use of Silicone intraocular lenses in patients with asteroid hyalosis has been associated with opacification of the implanted IOL.

Current openFDA PMA Record#

Device
TECNIS CL Foldable Silicone Intraocular Lens
Applicant
Johnson & Johnson Surgical Vision, Inc.
PMA number
P880081
Supplement
S042
Product code
HQL
Generic name
intraocular lens
Decision date
2019-04-05
Decision code
APPR
Date received
2019-03-08
Supplement type
Special (Immediate Track)
Supplement reason
Labeling Change - Indications/instructions/shelf life/tradename
Approval order statement
Approval to revise the TECNIS® CL, Model Z9002, Directions for Use (DFU) to inform the user of the interaction of silicone material with inherent risk factors (such as asteroid hyalosis) as follows:1) Addition of diabetic retinopathy as an example in Warning #10 to state: The use of silicone lenses in patients with current vitreoretinal disease or those who are at high risk for future vitreoretinal disease (i.e. diabetic retinopathy, etc.) that may require silicone oil as part of therapy should be reconsidered; and2) Addition of the following Warning #11: The use of Silicone intraocular lenses in patients with asteroid hyalosis has been associated with opacification of the implanted IOL.